JCM Accepts, published online ahead of print on 24 June 2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolffs, P. F.G.
Right arrow Articles by van den Brule, A. J.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolffs, P. F.G.
Right arrow Articles by van den Brule, A. J.C.

 Previous Article  |  Next Article 

J. Clin. Microbiol. doi:10.1128/JCM.02436-08
Copyright (c) 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Evaluation of MeningoFinder: a Novel MLPA Assay for Simultaneous Detection of Six Virus Species Causing Central Nervous System Infections

P. F.G. Wolffs*, C. Vink, J. Keijdener, B. Habek, M. Reijans, G. Simons, C. A. Bruggeman, and A. J.C. van den Brule

Department of Medical Microbiology, Maastricht University Medical Center, 6202 AZ, Maastricht, The Netherlands; PathoFinder B.V., 6229 EV Maastricht, The Netherlands; Laboratory for Pathology and Medical Microbiology, PAMM Laboratories, 5623 EJ Eindhoven, The Netherlands

* To whom correspondence should be addressed. Email: p.wolffs{at}mumc.nl.


arrow
Abstract

A multiplex ligation-dependent probe amplification (MLPA) assay for simultaneous detection of 6 virus species was developed and tested on clinical cerebrospinal fluids. The assay, termed MeningoFinder, showed an accordance of 97%, a concordance of 96%, an inter-laboratory sensitivity of 90% and an inter-laboratory specificity of 94% when compared to PCRs.